• Español
Logotipo BioKeralty
  • Home
  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Contact
/ Areas and lines of research / Genomics and personalized medicine

Genomics and personalized medicine

Areas and lines of research

The R+D+i work carried out by BioKeralty is carried out thanks to its participation in projects at a national and international level in collaboration with various strategic partners and entities. Our research work encompasses a wide variety of areas within which different lines of research and projects can be identified.


  • Primary care

  • Cancer

  • Chronic and neurodegenerative diseases

  • Infectious diseases

  • E-health

  • Genomics and personalized medicine

  • Regenerative medicine

  • Nanotechnology

  • Education

  • Community

  • Social

  • Health value

Genomics and personalized medicine

Genomics (also known as personalized medicine) seeks to identify genetic, environmental and lifestyle factors to prevent, diagnose or treat a disease. Genomics has been also defined as “precision medicine".

Nowadays, this new discipline is being implemented in the traditional health system being the increase in patient’s awareness, the expansion of infrastructures and the improvement of information management some examples. The permanent collaboration with clinics and institutes (both public and private) is essential for the establishment of national and international alliances to normalize personalized medicine practice in the clinical setting.

Today, the main interest areas are, on the one hand, the development of genetic tests for neurodegenerative, metabolic, orphan and oncological diseases and, on the other hand, the development of personalized medical devices for their application in regenerative medicine. As well, it is also remarkable the work done on the implementation of a genomic sequencing platform able to analyze, interpret and associate genetic variables in certain diseases.

Research areas and projects:

Line 1 – Predictive medicine

It is focused on the development of genetic tests for neurodegenerative, metabolic, orphan and oncological diseases.

Line 2 – Personalized medicine

This specialty is oriented to the development of personalized medical devices for application in other medicine specialties such as regenerative medicine.

Line 3 – Genomic sequencing

Genomic sequencing seeks the development of a genomic sequencing platform that includes primary, secondary and tertiary analysis, not only of exomes but also of the entire genome to associate new genetic variables with the main diseases under study, such as, neurological disorders. congenital malformations, hematological problems (bleeding disorders) and cancer.

Awesome Image

  • C/Albert Einstein 25, Edificio E-3, 1ª planta Oficina 2

    Parque Tecnológico de Álava,

    01510 Miñano, Vitoria-Gasteiz (Álava), España

  • BioKeralty
  • Areas and lines of research
  • Projects
  • Resources
  • Legal
  • Privacy policy
  • Cookies policy
  • Contact

Copyright © BioKeralty 2023

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

BIOKERALTY
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.